Search

Search Constraints

You searched for: Author/Creator Boguniewicz, Mark

Search Results

1. 321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis. (25th January 2023)

2. A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion. Issue 4 (July 2016)

3. Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life. (4th July 2022)

4. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Issue 12 (4th November 2022)

5. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. (January 2023)

6. Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry. Issue 3 (30th March 2018)

7. Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis. Issue 11 (21st July 2022)

9. Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants. Issue 4 (13th April 2015)